Implementations by Phenotype

Title Phenotypesort descending Institution Algorithm Type Total Cases Total Controls PPV Sensitivity
Lipids Northwestern Implementation Lipids Northwestern University Case Only 92%
Lipids Implementation - Columbia Lipids Columbia University Case Only
PAD Marshfield Implementation Peripheral Arterial Disease - 2012 Marshfield Clinic Research Foundation Case Only 88% 97%
PAD Mayo Implementation Peripheral Arterial Disease - 2012 Mayo Clinic Case Only 91% 86%
PAD Northwestern Implementation Peripheral Arterial Disease - 2012 Northwestern University Case, Control 95%, 100% 100%, 82%
RBC Marshfield Implementation Red Blood Cell Indices Marshfield Clinic Research Foundation Case Only 96% 87%
RBC Mayo Implementation Red Blood Cell Indices Mayo Clinic Case Only 98% 94%
RBC Northwestern Implementation Red Blood Cell Indices Northwestern University Case Only 98% 91%
RBC Implementation - Columbia Red Blood Cell Indices Columbia University Case Only
T2D Marshfield Implementation Type 2 Diabetes Mellitus Marshfield Clinic Research Foundation Case, Control 99%, 98% 100%, 98%
T2D Northwestern Implementation Type 2 Diabetes Mellitus Northwestern University Case, Control 98%, 100% 100%, 100%
T2D Vanderbilt Implementation Type 2 Diabetes Mellitus Vanderbilt University Case, Control 100%, 100%
T2DM Implementation - Columbia Type 2 Diabetes Mellitus Columbia University Case, Control 293 478
WBC Implementation - Columbia White Blood Cell Indices Columbia University Case Only
WBC Marshfield Implementation White Blood Cell Indices Marshfield Clinic Research Foundation Case Only 90% 88%
WBC Northwestern Implementation White Blood Cell Indices Northwestern University Case Only 85% 100%
Resistant hypertension Implementation - Columbia Resistant hypertension Columbia University Case, Control 249 1,031
CDiff NU implementation - May 2012 chart review Clostridium Difficile Colitis Northwestern University Case, Control 90%, 95% 95%
Group Health implementation Clostridium Difficile Colitis Group Health Cooperative Case, Control 92%, 88%
Vanderbilt implementation Clostridium Difficile Colitis Case, Control 100%, 100%
Marshfield C-diff implementation Clostridium Difficile Colitis Marshfield Clinic Research Foundation Case, Control 21 10 100%, 100%
CDiff Implementation - Columbia Clostridium Difficile Colitis Columbia University Case, Control 107 139
Geisinger c.Diff eMERGE3 Implementation Clostridium Difficile Colitis Geisinger Case, Control 20 20 100%, 100% 100%, 100%
VU E3 implementation Clostridium Difficile Colitis Vanderbilt University Medical Center Case, Control
Mayo Clinic eMERGE III Implementation Clostridium Difficile Colitis Mayo Clinic Case, Control 103 4,494

Pages